Oral bisphosphonates and colorectal cancer

Use of oral bisphosphonates has been associated with a decreased risk of colorectal cancer (CRC), but the association may be related to residual confounding by healthy lifestyle or body mass index (BMI). Therefore, we conducted a prospective nested case-control study within the Kaiser Permanente, No...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogtmann, Emily, Corley, Douglas A., Almers, Lucy M., Cardwell, Chris R., Murray, Liam J., Abnet, Christian C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345000/
https://www.ncbi.nlm.nih.gov/pubmed/28281559
http://dx.doi.org/10.1038/srep44177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345000/
https://www.ncbi.nlm.nih.gov/pubmed/28281559
http://dx.doi.org/10.1038/srep44177

Ejemplares similares